Delivery Order SPE2DB20D1100-SPE2DB25FE0WX
Award Date 9/23/25
Potential Completion Date 10/15/25
Potential Value $57K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $55,852.80 to AmerisourceBergen Drug Corp for the supply of GAMUNEX-C 40 gram/400 mL vials. The contract is a firm fixed-price delivery order with an ultimate completion date of October 9, 2025, and was awarded on September 18, 2025. This award represents a non-set-aside competitive procurement, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical supply requirements. The performance location...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $116,360 to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of GAMUNEX-C 40 gram/400 mL vials. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of October 8, 2025, and performance to be executed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, demonstrating the contractor's ability to compete...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of GAMUNEX-C 20 gram/200 ml vials. The contract has a ceiling value of $2,382.50 and a performance period through April 16, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order valued at $34,908.00 to AmerisourceBergen Drug Corp for the supply of GAMUNEX-C 40 gram/400 milliliter vials. The contract was competitively awarded on August 20, 2025, with a firm fixed price structure and an ultimate completion date of September 11, 2025. This non-set-aside delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $40,532.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 milliliter vials, with an ultimate completion date of August 22, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of GAMUNEX-C 20 gram/200 milliliter vials valued at $11,801.40 with a firm fixed price. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract involves no set-aside designation and was competitively...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $9,722.10 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of 4,564,743,440 units of the pharmaceutical product GAMUNEX-C 10 GRAM/100 ML VIAL 100ML, with a completion date of June 20, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which allows the...
- The U.S. Department of Defense (DOD) Defense Logistics Agency (DLA) Troop Support Medical has awarded a delivery order contract valued at $28,854.48 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution services company. The delivery order is for the product GAMUNEX-C 40 GRAM/400 ML VIAL 400ML and has a period of performance through April 1, 2024. This award is part of a larger $999,999,999.00 indefinite delivery contract (IDC)...
- The Defense Logistics Agency awarded a $23,602.80 delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 mL vials on September 4, 2025, with completion targeted for September 25, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside procurement issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of GAMUNEX-C 5 gram/50 milliliter vials valued at $3,036.70. This non-set-aside, firm fixed-price delivery order will be completed by October 9, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal military and...